Literature DB >> 28112068

Coeliac disease and invasive pneumococcal disease: a population-based cohort study.

A Röckert Tjernberg1, J Bonnedahl2, M Inghammar3, A Egesten4, G Kahlmeter5, P Nauclér6, B Henriques-Normark7, J F Ludvigsson8.   

Abstract

Severe infections are recognized complications of coeliac disease (CD). In the present study we aimed to examine whether individuals with CD are at increased risk of invasive pneumococcal disease (IPD). To do so, we performed a population-based cohort study including 29 012 individuals with biopsy-proven CD identified through biopsy reports from all pathology departments in Sweden. Each individual with CD was matched with up to five controls (n = 144 257). IPD events were identified through regional and national microbiological databases, including the National Surveillance System for Infectious Diseases. We used Cox regression analyses to estimate hazard ratios (HRs) for diagnosed IPD. A total of 207 individuals had a record of IPD whereas 45/29 012 had CD (0·15%) and 162/144 257 were controls (0·11%). This corresponded to a 46% increased risk for IPD [HR 1·46, 95% confidence interval (CI) 1·05-2·03]. The risk estimate was similar after adjustment for socioeconomic status, educational level and comorbidities, but then failed to attain statistical significance (adjusted HR 1·40, 95% CI 0·99-1·97). Nonetheless, our study shows a trend towards an increased risk for IPD in CD patients. The findings support results seen in earlier research and taking that into consideration individuals with CD may be considered for pneumococcal vaccination.

Entities:  

Keywords:  Coeliac disease; pneumococcal infection; pneumococci; septicaemia

Mesh:

Year:  2017        PMID: 28112068      PMCID: PMC9507833          DOI: 10.1017/S0950268816003204

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  35 in total

1.  Socioeconomic position and education in patients with coeliac disease.

Authors:  Ola Olén; Erik Bihagen; Finn Rasmussen; Jonas F Ludvigsson
Journal:  Dig Liver Dis       Date:  2012-02-15       Impact factor: 4.088

Review 2.  Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes.

Authors:  P Elfström; J Sundström; J F Ludvigsson
Journal:  Aliment Pharmacol Ther       Date:  2014-10-01       Impact factor: 8.171

Review 3.  Hyposplenism in gastrointestinal disease.

Authors:  A F Muller; P J Toghill
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

4.  Effect of gluten-free diet on splenic hypofunction of adult coeliac disease.

Authors:  G R Corazza; M Frisoni; D Vaira; G Gasbarrini
Journal:  Gut       Date:  1983-03       Impact factor: 23.059

5.  Splenic function in childhood coeliac disease.

Authors:  G R Corazza; R Lazzari; M Frisoni; A Collina; G Gasbarrini
Journal:  Gut       Date:  1982-05       Impact factor: 23.059

6.  Invasive pneumococcal disease in patients with an underlying pulmonary disorder.

Authors:  M Inghammar; G Engström; G Kahlmeter; B Ljungberg; C-G Löfdahl; A Egesten
Journal:  Clin Microbiol Infect       Date:  2013-03-07       Impact factor: 8.067

7.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

8.  Validation study of villous atrophy and small intestinal inflammation in Swedish biopsy registers.

Authors:  Jonas F Ludvigsson; Lena Brandt; Scott M Montgomery; Fredrik Granath; Anders Ekbom
Journal:  BMC Gastroenterol       Date:  2009-03-11       Impact factor: 3.067

9.  Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden.

Authors:  Ilias Galanis; Ann Lindstrand; Jessica Darenberg; Sarah Browall; Priyanka Nannapaneni; Karin Sjöström; Eva Morfeldt; Pontus Naucler; Margareta Blennow; Åke Örtqvist; Birgitta Henriques-Normark
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

Review 10.  Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.

Authors:  Antoni Torres; Francesco Blasi; Nathalie Dartois; Murat Akova
Journal:  Thorax       Date:  2015-07-28       Impact factor: 9.139

View more
  5 in total

1.  Celiac disease and complement activation in response to Streptococcus pneumoniae.

Authors:  Anna Röckert Tjernberg; Hanna Woksepp; Kerstin Sandholm; Marcus Johansson; Charlotte Dahle; Jonas F Ludvigsson; Jonas Bonnedahl; Per Nilsson; Kristina Nilsson Ekdahl
Journal:  Eur J Pediatr       Date:  2019-11-05       Impact factor: 3.183

Review 2.  Immune response to vaccines in children with celiac disease.

Authors:  Caterina Anania; Francesca Olivero; Alessandra Spagnolo; Claudio Chiesa; Lucia Pacifico
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

3.  The use of an invitational letter to increase the vaccine uptake of patients with coeliac disease.

Authors:  Joseph Moneim; Hera Asad; Eman Butt; Jamil Shah Foridi; Yasmin Khan; Safwaan Patel; Jawad Qureshi; Ravi Thakar
Journal:  Prim Health Care Res Dev       Date:  2019-10-30       Impact factor: 1.458

Review 4.  Contribution of Infectious Agents to the Development of Celiac Disease.

Authors:  Daniel Sánchez; Iva Hoffmanová; Adéla Szczepanková; Věra Hábová; Helena Tlaskalová-Hogenová
Journal:  Microorganisms       Date:  2021-03-06

5.  Risk of Severe Covid-19 in Patients with Celiac Disease: A Population-Based Cohort Study.

Authors:  Benjamin Lebwohl; Emma Larsson; Jonas Söderling; Bjorn Roelstraete; Joseph A Murray; Peter H R Green; Jonas F Ludvigsson
Journal:  Clin Epidemiol       Date:  2021-02-18       Impact factor: 4.790

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.